Who is sponsoring NCT07164222?

NCT07164222 is sponsored by Assiut University.

What drugs are being tested in NCT07164222?

Interventions in NCT07164222: Glycated haemoglobin and triglycerides level.

What condition does NCT07164222 study?

NCT07164222 studies Triglycerides Glucose Index and Ratio on Diabetic Type 2.

Is NCT07164222 still recruiting?

NCT07164222 is currently not yet recruiting. Last updated 10 September 2025.

Last reviewed 2025-09-10 · How we verify

NCT07164222: Diabetes 2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Triglycerides Glucose Index and Ratio on Diabetic Type 2

Not yet recruiting Last updated 10 September 2025

What this trial tests

trial testing Glycated haemoglobin and triglycerides level in Triglycerides Glucose Index and Ratio on Diabetic Type 2 in 200 participants. Not yet recruiting.

Timeline

30 September 2025

Primary endpoint
30 September 2027

30 September 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	200
Start date	30 September 2025
Primary completion	30 September 2027
Estimated completion	30 September 2027

Drugs / interventions tested

Glycated haemoglobin and triglycerides level

Conditions studied

Triglycerides Glucose Index and Ratio on Diabetic Type 2 — all drugs for Triglycerides Glucose Index and Ratio on Diabetic Type 2 →

Sponsor

Assiut University

Who can join

Adults 18 to 65, any sex, with Triglycerides Glucose Index and Ratio on Diabetic Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Triglycerides glucose index and ratio on diabetic type 2

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07164222 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 10 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07164222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing